Guoling Chen | Director, Quality Operations
in8bio

Guoling has over 10 years experience in health care and, research, in both academia and industry settings, 7 years of which are in cell therapy product manufacturing and quality aspects, including both minimally-manipulated and more-than-minimally-manipulated cell therapy products. Guoling is currently the Director of Quality Operations at IN8bio Inc., headquartered at New York US, a clinical-stage biopharmaceutical company specializing in development and commercialization of gamma-delta T cell therapies for the treatment of cancer.